Is a complete TPEX/6461 research report available?

No complete published report is available for tpex/6461 (TPEX/6461) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/6461 (TPEX/6461)

Taipei Exchange: TPEX/6461 · TWD

NT$25.6

+1.25 (+5.1%)· Recorded snapshot

Market cap	2.8B
Revenue (ttm)	48.6M
Net income (ttm)	-482M
EPS (ttm)	-NT$4.60
Shares out	110.3M
Volume	113,332
Beta	0.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 48.6M
Net income (ttm): -482M
EPS (ttm): -NT$4.60
Market cap: 2.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-12 02:00 UTC

All TPEX/6461 indicators

Market & fundamental data

Available fields

177

Groups with data

Currency

TWD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	96
Employees Change	6%
Employees Change Percent	6.67
Enterprise value	TWD 4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	32.5
Isin	TW0006461007
Last refreshed	2026-09-12
Market cap	TWD 2.8B
Price	TWD 25.55
Price currency	TWD
Sector	Healthcare
Sector PE	88.31
Sector PE Fwd	27.72
Sic	2834
Symbol	tpex/6461
Website	https://www.intechbiopharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.1%
EV/Sales	82.42x
FCF yield	-14.25%
P/B ratio	3.15x
P/S ratio	58.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	TWD -185.7M
Net Income	TWD -482M
Net Income Growth Years	0%
Pretax Margin	-992.81%
ROA	-11.56
Roa5y	-8.14
ROCE	-22.5
ROE	-47.57
Roe5y	-31.76
ROIC	-11.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.76%
Cagr1y	-16.61%
Cagr3y	-17.24%
Cagr5y	-5.57%
EPS Growth Years	4
Revenue Growth	-57.87x
Revenue Growth Q	-78.54x
Revenue Growth Qo Q	6.9x
Revenue Growth Years	3x
Revenue Growth3 Y	33.66x
Revenue Growth5 Y	18.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.02
Assets	TWD 2.3B
Cash	TWD 145.4M
Current Assets	TWD 370.6M
Current Liabilities	TWD 228.7M
Debt	TWD 1.3B
Debt Equity	TWD 1.49
Debt FCF	TWD -3.31
Equity	TWD 894.4M
Interest Coverage	-14.43
Liabilities	TWD 1.4B
Long Term Assets	TWD 1.9B
Long Term Liabilities	TWD 1.2B
Net Cash	TWD -1.2B
Net Cash By Market Cap	TWD -41.97
Net Debt Equity	TWD 1.32
Tangible Book Value	TWD 889.2M
Tangible Book Value Per Share	TWD 8.06
WACC	3.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.62
Inventory Turnover	1.65
Net Working Capital	TWD 170.8M
Quick ratio	0.94
Working Capital	TWD 141.9M
Working Capital Turnover	TWD 0.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-60.01%
1Y total return	-16.6%
200-day SMA	28.07
3Y total return	-43.33%
50-day SMA	25.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-24.93%
All Time High	203.7
All Time High Change	-87.46%
All Time High Date	2014-07-15
All Time Low	18.51
All Time Low Change	38.03%
All Time Low Date	2020-03-23
ATR	1.21
Beta	0.11
Beta1y	0.34
Beta2y	0.49
Ch YTD	-11.21
High	25.85
High52	42.44
High52 Date	2026-03-02
High52ch	-39.79%
Low	24.1
Low52	22.79
Low52 Date	2025-11-24
Low52ch	12.09%
Ma50ch	0.19%
Price vs 200-day SMA	-8.99%
RSI	48.78
RSI Monthly	40.91
RSI Weekly	45
Sharpe ratio	-0.24x
Sharpe Ratio3y	-0.37x
Sharpe Ratio5y	0.01x
Sortino ratio	-0.26
Sortino Ratio3y	-0.44
Sortino Ratio5y	0.15
Total Return	-22.4%
Tr YTD	-11.21
Tr1m	-0.91%
Tr1w	-0.78%
Tr3m	-0.6%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	59,149,418%
Net Borrowing	35,614,000
Shares Insiders	1.02%
Shares Institutions	5.94%
Shares Out	110,324,691
Shares Qo Q	-2.52%
Shares Yo Y	22.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -419.9M
Adjusted OCF	-375,534,000
Average Volume	93,955.85x
Bv Per Share	8.11
CAPEX	TWD -44.3M
Ch10y	-61.91
Ch1m	-0.91
Ch1w	-0.78
Ch1y	-16.6
Ch3m	-0.6
Ch3y	-45.69
Ch5y	-28.49
Ch6m	-21.37
Change	5.14%
Change From Open	5.14
Close	24.3
Days Gap	0
Depreciation Amortization	90,727,000
Dollar Volume	2,895,632.6
Earnings Date	2026-11-11
EBIT	TWD -465.1M
EBITDA	TWD -374.3M
EPS	TWD -4.6
F Score	1
FCF	TWD -401.6M
FCF EV Yield	-10.03x
FCF Per Share	TWD -3.64
Financing CF	3,060,000
Fiscal Year End	December
Founded	2,010
Investing CF	153,915,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2026-06-30
Last Split Date	2026-09-09
Last Split Type	Reverse
Ma150	28.4
Ma150ch	-10.03%
Ma20	25.83
Ma20ch	-1.07%
Net CF	-200,680,000
Next Earnings Date	2026-11-11
Open	24.3
Position In Range	82.86
Ppne	1,380,758,000
Price Date	2026-09-11
Ptbv Ratio	3.17
Relative Volume	1.21x
Revenue	48,551,000x
SBC By Revenue	37.69x
Share Based Comp	18,297,000
Tr6m	-21.37%
Volume	113,332
Z Score	0.59

TPEX/6461 (TPEX/6461)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6461

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6461 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6461

Frequently asked questions